当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort
Hepatology ( IF 12.9 ) Pub Date : 2021-12-16 , DOI: 10.1002/hep.32281
Loreta A Kondili 1 , Monica Monti 2 , Maria Giovanna Quaranta 1 , Laura Gragnani 2 , Valentina Panetta 3 , Giuseppina Brancaccio 4 , Cesare Mazzaro 5 , Marcello Persico 6 , Mario Masarone 6 , Ivan Gentile 7 , Pietro Andreone 8 , Salvatore Madonia 9 , Elisa Biliotti 10 , Roberto Filomia 11 , Massimo Puoti 12 , Anna Ludovica Fracanzani 13 , Diletta Laccabue 14 , Donatella Ieluzzi 15 , Carmine Coppola 16 , Maria Grazia Rumi 17 , Antonio Benedetti 18 , Gabriella Verucchi 19 , Barbara Coco 20 , Liliana Chemello 21 , Andrea Iannone 22 , Alessia Ciancio 23 , Francesco Paolo Russo 24 , Francesco Barbaro 25 , Filomena Morisco 26 , Luchino Chessa 27 , Marco Massari 28 , Pierluigi Blanc 29 , Anna Linda Zignego 2
Affiliation  

Mixed cryoglobulinemia is the most common HCV extrahepatic manifestation. We aimed to prospectively evaluate the cryoglobulinemic vasculitis (CV) clinical profile after a sustained virologic response (SVR) over a medium-term to long-term period.

中文翻译:


意大利 PITER 队列对 HCV 冷球蛋白血症性血管炎的直接抗病毒有效性和复发风险进行的前瞻性研究



混合性冷球蛋白血症是最常见的 HCV 肝外表现。我们的目的是前瞻性评估中长期持续病毒学应答(SVR)后的冷球蛋白血症性血管炎(CV)临床特征。
更新日期:2021-12-16
down
wechat
bug